Gallic Acid

Gallic Acid

SCHEMBL1065001

N.N.O=C(O)c1cc(O)c(O)c(O)c1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.94
CA1 P00915 4/20 0.94
CA2 P00918 4/20 0.94
CA7 P43166 4/20 0.94
CA9 Q16790 4/20 0.94
CA14 Q9ULX7 4/20 0.94
KDM4E B2RXH2 4/20 0.94
MAPT P10636 3/20 0.94
CA4 P22748 3/20 0.94
CA6 P23280 3/20 0.94
LMNA P02545 3/20 0.94
TDP1 Q9NUW8 3/20 0.94
ALDH1A1 P00352 2/20 0.94
FUT7 Q11130 2/20 0.94
CA3 P07451 2/20 0.94
CA5A P35218 2/20 0.94
CA5B Q9Y2D0 2/20 0.94
TP53 P04637 1/20 0.94
SELL P14151 1/20 0.94
HPGD P15428 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gallic Acid SCHEMBL210236 1.00 CA12 (0.94) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL27880291 0.97 CA12 (0.90) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL28331566 0.97 CA12 (0.90) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL30375631 0.97 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL678990 0.97 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL29484566 0.97 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL15012 0.97 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL4918056 0.97 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL8088102 0.97 CA12 (1.00) CA12CA1CA2CA7CA9
Gallic Acid SCHEMBL1845406 0.97 CA12 (1.00) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2263996-B1 PROCESS FOR PRODUCING DIAMINE AND POLYAMIDE TORAY INDUSTRIES (JP) 2016-09-14 EP disclosed
US-8334411-B2 Process for producing diamine and polyamide TORAY INDUSTRIES, INC. (JP) 2012-12-18 US disclosed
US-20110004018-A1 PROCESS FOR PRODUCING DIAMINE AND POLYAMIDE TORAY INDUSTRIES, INC. (JP) 2011-01-06 US disclosed
EP-2263996-A1 PROCESS FOR PRODUCING DIAMINE AND POLYAMIDE Toray Industries, Inc. (JP) 2010-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110004018-A1 PROCESS FOR PRODUCING DIAMINE AND POLYAMIDE NAAA, PUF60, DNPEP CA12 256/4885CA1 396/4885CA2 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.